Actively Recruiting

Phase Not Applicable
Age: 18Years +
MALE
NCT07324798

Adaptive Radiotherapy for Genitourinary Cancers

Led by Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Updated on 2026-01-07

60

Participants Needed

1

Research Sites

213 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to learn if adaptive radiation boost works to treat genitourinary cancers, esp. in the context of prostate cancer patients with post-prostatectomy local relapse and bladder cancer patients with bladder-conserving treatment. It will also learn about the safety and efficacy of adaptive boost. The main questions it aims to answer are: Does adaptive boost lower the toxicities? Does adaptive boost maintain or improve the clinical efficacy? Participants will: Undergo adaptive boost on 1.5-Tesla MR-Linac Visit the clinic once every 2 weeks during RT, and every 3 months post-ART Keep a regular QOL questinnaire completion

CONDITIONS

Official Title

Adaptive Radiotherapy for Genitourinary Cancers

Who Can Participate

Age: 18Years +
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with newly diagnosed or metastatic/recurrent pathologically confirmed urological tumors, clinically assessed as suitable for adaptive radiotherapy
  • Age 18 years or older
  • ECOG performance status score 0-2
  • No prior radiotherapy history within the current radiation field
  • No contraindications for MRI scanning
  • No contraindications for radiotherapy
Not Eligible

You will not qualify if you...

  • Patients with contraindications to radiotherapy
  • Patients unable to tolerate MRI or with contraindications to MRI scanning

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Cancer Hospital, National Cancer Center, CAMS & PUMC

Beijing, Beijing Municipality, China, 100021

Actively Recruiting

Loading map...

Research Team

N

Ning-Ning Lu, M.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Adaptive Radiotherapy for Genitourinary Cancers | DecenTrialz